Business
Announcement on the Reply to the Regulatory Business Letter from SSE on Information Disclosure for Qinghai Spring’s Report for Q3 2025
Announcement on the Reply to the Regulatory Business Letter from SSE on Information Disclosure for Qinghai Spring’s Report for Q3 2025
About this update from Qinghai Spring Medicinal Resources Technology Co.,ltd. Class A
Announcement on the Reply to the Regulatory Business Letter from SSE on Information Disclosure for Qinghai Spring’s Report for Q3 2025 The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment